Source: Health Products Regulatory Authority (IE) Revision Year: 2015 Publisher: Boehringer Ingelheim Limited, Ellesfield Avenue, Bracknell, Berkshire RG12 8YS, United Kingdom
Dixarit Tablets 25 micrograms.
| Pharmaceutical Form |
|---|
|
Coated tablet. Blue, biconvex, sugar-coated tablets. |
Each tablet contains clonidine hydrochloride 25 micrograms.
Excipients with known effect: Each tablet contains 16.85 mg lactose and 20.388 mg sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clonidine |
Clonidine has been shown to have both central and peripheral sites of action. With long-term treatment clonidine reduces the responsiveness of peripheral vessels to vasoconstrictor and vasodilator substances and to sympathetic nerve stimulation. Early in treatment, however, blood pressure reduction is associated with a central reduction of sympathetic outflow and increased vagal tone. |
| List of Excipients |
|---|
|
Tablet core: Calcium hydrogen phosphate, anhydrous Tablet coating: Povidone |
PVC/aluminium blister packs of 84, 100, 112.
Currently the 112 pack is the only marketed pack.
Boehringer Ingelheim Limited, Ellesfield Avenue, Bracknell, Berkshire RG12 8YS, United Kingdom
PA 0007/032/001
Date of first authorisation: 07 May 1987
Date of last renewal: 01 November 2005
| Drug | Countries | |
|---|---|---|
| DIXARIT | Estonia, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
